Globyz
Provider of supply-chain, regulatory and commercialization services for life-science organizations operating in North America and selected international markets. Offers comparator sourcing and clinical trial supply, clinical secondary packaging and labeling, temperature-controlled logistics, GMP/GDP-compliant warehousing and 3PL, regulatory affairs support for Canadian market entry (MDEL/DEL/NHP), and commercialization services.
Industries
Nr. of Employees
medium (51-250)
Services
Procurement and supply management for clinical trials including comparator drug sourcing, cold-chain handling and distribution to study sites.
Secondary packaging and labeling services for clinical and commercial products with controlled workflows to support regulatory compliance.
Validated cold-chain shipping, environmental monitoring, and courier coordination for temperature-sensitive products.
Third-party logistics including GDP/cGMP-validated storage, pick/pack/ship, returns and recall handling, and real-time inventory visibility.
Regulatory advisory and operational support for Canadian product and site licensing (MDEL/DEL/NHP), labelling, and documented procedure alignment.
Support for customs clearance, registered importer services and regulatory alignment for cross-border shipments into the U.S. and Canada.
Procurement and supply management for clinical trials including comparator drug sourcing, cold-chain handling and distribution to study sites.
Secondary packaging and labeling services for clinical and commercial products with controlled workflows to support regulatory compliance.
Validated cold-chain shipping, environmental monitoring, and courier coordination for temperature-sensitive products.
Third-party logistics including GDP/cGMP-validated storage, pick/pack/ship, returns and recall handling, and real-time inventory visibility.
Regulatory advisory and operational support for Canadian product and site licensing (MDEL/DEL/NHP), labelling, and documented procedure alignment.
Support for customs clearance, registered importer services and regulatory alignment for cross-border shipments into the U.S. and Canada.
Expertise Areas
- Clinical trial supply management
- Cold-chain logistics and temperature-controlled distribution
- GMP/GDP-compliant 3PL warehousing and fulfillment
- Canadian regulatory compliance (MDEL, DEL, NHP site/product licensing)
Key Technologies
- EPCIS-based serialization and traceability
- 21 CFR Part 11-compliant electronic record systems
- Temperature-mapping and cold-chain monitoring systems
- Cold-chain validated packaging and environmental monitoring
News & Updates
Overview of Health Canada Phase 2 MDEL amendments, including distributor exemptions, supplier-list disclosure, and documented procedures enforcement.
Explains who requires a DEL and options for foreign companies, including partnering with an established DEL holder to enable market entry without building local infrastructure.
Explains the distinction between a product licence and an MDEL and the role of an MDEL holder for market access in Canada.
Guidance for international Natural Health Product brands on licensing, importer selection, labelling and supply-chain responsibilities for sale in Canada.
Discusses comparator sourcing strategy considerations to reduce time and cost when procuring drugs for clinical trials.
Overview of Health Canada Phase 2 MDEL amendments, including distributor exemptions, supplier-list disclosure, and documented procedures enforcement.
Explains who requires a DEL and options for foreign companies, including partnering with an established DEL holder to enable market entry without building local infrastructure.
Explains the distinction between a product licence and an MDEL and the role of an MDEL holder for market access in Canada.
Guidance for international Natural Health Product brands on licensing, importer selection, labelling and supply-chain responsibilities for sale in Canada.
Discusses comparator sourcing strategy considerations to reduce time and cost when procuring drugs for clinical trials.